Dr. Hao Song is the ARC DECRA & NHMRC Emerging Leadership Fellow at the Australian Institute for Bioengineering and Nanotechnology (AIBN), the University of Queensland. Dr. Song's research aims to develop novel nanomaterials for efficient gene and vaccine delivery. He has published over 65 papers in field-leading journals, including JACS, Adv Mater, Angew Chem Int Ed, Adv Sci, attracting citations over 3200 times with an H-index of 31. He is an ECR Committee member of Controlled Release Society Australia and the Associate Editor for Frontiers in Drug Delivery. He has attracted around AUD$2.0 million of funding as chief investigator and promoted his technology translation in collaboration with several industrial partners.